Advancing New Healthcare Solutions Through Collaboration

(Fierce Biotech) During a Fierce JPM Week executive interview, Melinda Richter, Global Head of Johnson & Johnson Innovation – JLABS, discusses the big company advantage of the global incubator network offers to early-stage innovators.

Visionaries are invited to submit methods and technologies aiming to optimize patient care for immunotherapies within the hematologic malignancy space by enabling early detection of neurotoxic events.

As we look to the future of preventing, intercepting, and curing disease, Dr. Bill Hait shares how bold thinking and first-of-its-kind collaboration can help us get there.

Johnson & Johnson Innovation is committed to working with the innovator community around the world with the aim to continue to accelerate potential transformational healthcare solutions during this unprecedented time.